
pmid: 19447241
Antineoplastic Agents, Breast Neoplasms, Docetaxel, United Kingdom, Clinical Trials, Phase III as Topic, Chemotherapy, Adjuvant, Drug Resistance, Neoplasm, Research Design, Antineoplastic Combined Chemotherapy Protocols, Humans, Female, Taxoids, Fluorouracil, Cyclophosphamide, Epirubicin, Randomized Controlled Trials as Topic
Antineoplastic Agents, Breast Neoplasms, Docetaxel, United Kingdom, Clinical Trials, Phase III as Topic, Chemotherapy, Adjuvant, Drug Resistance, Neoplasm, Research Design, Antineoplastic Combined Chemotherapy Protocols, Humans, Female, Taxoids, Fluorouracil, Cyclophosphamide, Epirubicin, Randomized Controlled Trials as Topic
| citations This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | 3 | |
| popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network. | Average | |
| influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | Average | |
| impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network. | Average |
